Multicenter Phase II Trial of Durvalumab (MEDI4736) With Trastuzumab and Pertuzumab Combination in HER2-Enriched and HER2-Amplified Breast Cancer (DTP Trial)

Chang, Jenny C. (PI)
Arentz, Candy (Key Personnel)
Mai, Hanh P. (Key Personnel)
Niravath, Polly A. (Key Personnel)
Sun, Kai (Key Personnel)

Houston Methodist

Project: Clinical Trial

Status	Not started